{"cik":2088082,"taxonomy":"us-gaap","tag":"AllocatedShareBasedCompensationExpense","label":"Share-based Payment Arrangement, Expense","description":"Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.","entityName":"Electra Therapeutics, Inc.","units":{"USD":[{"start":"2025-01-01","end":"2025-09-30","val":1207000,"accn":"0001193125-26-458476","fy":2026,"fp":"Q3","form":"10-Q","filed":"2026-11-12"},{"start":"2025-07-01","end":"2025-09-30","val":302000,"accn":"0001193125-26-458476","fy":2026,"fp":"Q3","form":"10-Q","filed":"2026-11-12","frame":"CY2025Q3"},{"start":"2026-01-01","end":"2026-09-30","val":7200000,"accn":"0001193125-26-458476","fy":2026,"fp":"Q3","form":"10-Q","filed":"2026-11-12"},{"start":"2026-07-01","end":"2026-09-30","val":4592000,"accn":"0001193125-26-458476","fy":2026,"fp":"Q3","form":"10-Q","filed":"2026-11-12","frame":"CY2026Q3"}]}}